Purtill served as interim president and chief executive officer since August 2022.
Previously, he served as the senior vice president and general manager, EMEA and APAC since December 2021 and vice president, Global Strategy and general manager, Asia Pacific, since September 2021.
Previously, he served for 11 years as the company's vice president and general manager, Asia Pacific region.
Prior to joining Invacare, he held various sales, category management and supply chain leadership roles at Johnson & Johnson and Nestle.
Purtill spent 14 years in the Australian Army where he was a Captain in the Intelligence Corps.
Invacare Corp. is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings.
At its core, the company designs, manufactures and distributes medical devices that help people to move, rest and perform essential hygiene.
The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, elderly, bariatric) ailments.
The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer